好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Quality of Life for Younger Versus Older Patients Following Endovascular Thrombectomy in the Extended Window: A Secondary Analysis of DEFUSE 3
Cerebrovascular Disease and Interventional Neurology
S20 - Cerebrovascular Disease: Large Vessel Occlusions and Thrombectomy (4:54 PM-5:06 PM)
008

To determine if younger, compared to older, patients have differences in quality of life (QoL) after large vessel occlusion (LVO) stroke treated with endovascular thrombectomy (EVT) in the extended window (6-16 hours from last normal).  

The QoL effects of LVO stroke on younger versus older patients has not been adequately explored.

We included patients randomized to EVT in DEFUSE 3. We divided the cohort into younger (≤60 years) versus older (>60). The primary outcome was a 32-question neurological QoL scale (n-QoL), measured at 90 days from stroke. We allocated the n-QoL into 8-questions domains: functional, psychological, social/activity, and cognitive. Higher scores reflect better QoL in the functional, social/activity, and cognitive domains, but lower QoL in the psychological domain. We tested differences in the mean QoL score by Student’s t-test and fit linear regression models to the domains’ QoL score, adjusted for sex, race/ethnicity, tPA administration, TOAST category, ischemic core volume, and post-procedural TICI score.

We included 72 patients, of which 23 (31.9%) were ≤60 and 49 (68.1%) were >60. The mean QoL score by domain for younger versus older patients was: functional=4.0 vs. 3.5 (p=0.116), psychologic=1.3 vs. 1.8 (p=0.013), social/activity=3.8 vs. 3.2 (p=0.151) and cognitive=4.1 vs. 3.6 (p=0.073). In the adjusted regression models, younger age was associated with better social/activity (β coefficient=0.83, p=0.047) and psychological (β coefficient= -0.55, p=0.020) domain scores, but not cognitive or functional domain scores. The proportion of younger versus older patients with good outcome (modified Rankin Scale 0-2) was not significantly different (chi-squared test, p=0.147), nor was the ordinal mRS (Mann-Whitney U test, p=0.153).

Although these findings are preliminary, our analysis suggests younger LVO stroke patients treated with EVT in the extended window have better psychological and social/activity QoL outcomes compared to older patients. This underappreciated impact of LVO stroke on older patients warrants additional research. 

Authors/Disclosures
Adam De Havenon, MD, FAAN (Yale University)
PRESENTER
Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has stock in Certus. Dr. De Havenon has stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Jennifer J. Majersik, MD, FAAN (University of Utah) Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS.
No disclosure on file
No disclosure on file
Gregory W. Albers, MD (Stanford University) No disclosure on file